SCHEMBL7614902

SCHEMBL7614902

CC(=O)NC(C)(CCc1cccc(O)c1)COC(C)=O.CC(=O)NC(C)(CCc1cccc(OCc2ccccc2)c1)COC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.45
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
CYP2D6 P10635 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
FFAR1 O14842 1/20 0.42
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
LTB4R Q15722 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.41
NR4A2 P43354 1/20 0.41
SMPD1 P17405 1/20 0.41
BCHE P06276 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PKM P14618 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714226 0.96 MAOB (0.48) MAOBCYP4F2CYP4A11CYP2D6MEN1
SCHEMBL7618088 0.89 SPR (0.42) ALDH1A1
SCHEMBL7620391 0.87 CYP2D6 (0.46) CYP2D6
SCHEMBL7622109 0.85 MAOB (0.42) MAOBCYP4F2CYP4A11CYP2D6MEN1
SCHEMBL7619561 0.84 CYP2D6 (0.40) MAOBCYP4F2CYP4A11CYP2D6MEN1
SCHEMBL7614876 0.81 ALDH1A1 (0.46) ALDH1A1MAPTTHRBRAB9A
SCHEMBL7714053 0.81 CYP2D6 (0.50) CYP2D6SMPD1
SCHEMBL7716382 0.81 MAOB (0.46) MAOBCYP4F2CYP4A11CYP2D6MEN1
SCHEMBL7622541 0.74 CYP2D6 (0.46) CYP2D6SMPD1
Hydrochloric Acid SCHEMBL7622475 0.74 S1PR1 (0.44) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1220905-A2 COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES Genentech Inc. (US) 2002-07-10 EP disclosed
EP-0778263-B1 BENZENE COMPOUND AND MEDICINAL USE THEREOF WELFIDE CORP (JP) 2002-01-09 EP disclosed
WO-2000053758-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES GENENTECH, INC. (US) 2000-09-14 WO disclosed